See All Slides - tctmd.com

Slides

Presentation TVT 2015

Case Presentation: Bioprosthetic Aortic Valve Failure and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Jonathon M. White

June 04, 2015

Presentation TVT 2015

Should the Minimalist Approach Change for Intermediate- and Low-Risk TAVR Patients?

Presenter: Vinayak Bapat

June 04, 2015

Presentation TVT 2015

Case Examples and Discussion

Presenter: Raj Makkar

June 04, 2015

Presentation TVT 2015

Thoughtful Commentary: Severe Asymptomatic AS and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Allan Schwartz

June 04, 2015

Presentation TVT 2015

Case Presentation: Severe Asymptomatic AS and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Vasilis Babaliaros

June 04, 2015

Presentation TVT 2015

A Worldwide View of the MitraClip: Utilization and Results From Registries

Presenter: Ted Feldman, Francesco Maisano, Brian K. Whisenant, Stephan Baldus

June 04, 2015

Presentation TVT 2015

Reduced or No Predilatation Before TAVR Should Be Part of the Minimalist Approach

Presenter: Georg Nickenig

June 04, 2015

Presentation TVT 2015

Technology Essentials, Implantation Guidelines, and Clinical Trial Results

Presenter: Ganesh Manoharan

June 04, 2015

Presentation TVT 2015

The Vancouver Postprocedural Clinical Pathway for Safe Next-Day Discharge Home

Presenter: Sandra Lauck

June 04, 2015

Presentation TVT 2015

Thoughtful Commentary: Severe Renal Disease and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, E. Murat Tuzcu

June 04, 2015

Advertisement

Slides

Case Presentation: Bioprosthetic Aortic Valve Failure and TAVR

Should the Minimalist Approach Change for Intermediate- and Low-Risk TAVR Patients?

Case Examples and Discussion

Thoughtful Commentary: Severe Asymptomatic AS and TAVR

Case Presentation: Severe Asymptomatic AS and TAVR

A Worldwide View of the MitraClip: Utilization and Results From Registries

Reduced or No Predilatation Before TAVR Should Be Part of the Minimalist Approach

Technology Essentials, Implantation Guidelines, and Clinical Trial Results

The Vancouver Postprocedural Clinical Pathway for Safe Next-Day Discharge Home

Thoughtful Commentary: Severe Renal Disease and TAVR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content